Back to results
US 10,954,202 B2Granted
Protein tyrosine phosphatase inhibitors and methods of use thereof
AssigneeAbbVie Inc.
InventorsZhaoming Xiong, Jennifer M. Frost, Philip R. Kym, Xueqing Wang, Shuang Chen, Dennie Welch
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.
Claims4
A compound, wherein the compound is
A compound, wherein the compound is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.